Uncategorized
Allegro, Hanmi enter license agreement for Luminate in Korea, China
Allegro Ophthalmics and Hanmi Pharmaceutical have entered into a license agreement for Luminate in the Republic of Korea and the People’s Republic of China, according to a press release from Allegro.Under the license agreement, Hanmi will pay Allegro upfront licensing fees, sales milestone payments and running royalties as a percentage of net sales. Hanmi will also make a $20 million strategic investment in Allegro, the release said.